AU2001292125A1 - Genetic factors affecting the outcome of viral infections - Google Patents

Genetic factors affecting the outcome of viral infections

Info

Publication number
AU2001292125A1
AU2001292125A1 AU2001292125A AU9212501A AU2001292125A1 AU 2001292125 A1 AU2001292125 A1 AU 2001292125A1 AU 2001292125 A AU2001292125 A AU 2001292125A AU 9212501 A AU9212501 A AU 9212501A AU 2001292125 A1 AU2001292125 A1 AU 2001292125A1
Authority
AU
Australia
Prior art keywords
outcome
viral infections
factors affecting
genetic factors
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292125A
Inventor
Angela Frodsham
Adrian Hill
Howard Thomas
Mark Thursz
Lyna Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of AU2001292125A1 publication Critical patent/AU2001292125A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001292125A 2000-10-05 2001-10-05 Genetic factors affecting the outcome of viral infections Abandoned AU2001292125A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0024442A GB0024442D0 (en) 2000-10-05 2000-10-05 Genetic factors affecting the outcome of viral infections
GB0024442.6 2000-10-05
PCT/GB2001/004472 WO2002029098A2 (en) 2000-10-05 2001-10-05 Genetic factors affecting the outcome of viral infections

Publications (1)

Publication Number Publication Date
AU2001292125A1 true AU2001292125A1 (en) 2002-04-15

Family

ID=9900751

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292125A Abandoned AU2001292125A1 (en) 2000-10-05 2001-10-05 Genetic factors affecting the outcome of viral infections

Country Status (3)

Country Link
AU (1) AU2001292125A1 (en)
GB (1) GB0024442D0 (en)
WO (1) WO2002029098A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033738A2 (en) * 2001-10-16 2003-04-24 Kabushiki Kaisha Toshiba Polymorphic marker that can be used to assess the efficacy of interferon therapy
ATE493142T1 (en) * 2003-11-05 2011-01-15 Inst Rech Developpement Ird IL-22 TO PREVENT INFECTIOUS DISEASES
CN101361968B (en) 2007-08-06 2011-08-03 健能隆医药技术（上海）有限公司 Use of interleukin-22 in treating fatty liver
CN102172395A (en) * 2007-11-07 2011-09-07 健泰科生物技术公司 Compositions and methods for treatment of microbial disorders
WO2010149767A1 (en) 2009-06-25 2010-12-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for determining the risk of occurence of liver fibrosis in an individual
CN102260343A (en) 2010-05-25 2011-11-30 健能隆医药技术（上海）有限公司 Application of recombinant human G-CSF dimer for treating nerve damage disease
CN102380091A (en) * 2010-08-31 2012-03-21 健能隆医药技术（上海）有限公司 Application of interleukin-22 in curing virus hepatitis
US9642917B2 (en) 2011-07-25 2017-05-09 Generon (Shanghai) Corporation, Ltd. Use of G-CSF dimer in preparation of medicament for treatment of neurodegenerative diseases
CN103182072B (en) 2011-12-27 2017-05-03 健能隆医药技术（上海）有限公司 Application of interleukin-22 in treating and preventing nerve injuries and neurodegeneration diseases
US20150246095A1 (en) * 2012-10-03 2015-09-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza
TR201809571T4 (en) 2013-03-15 2018-07-23 Hoffmann La Roche IL-22 polypeptides and IL-22 fc fusion proteins and methods of use.
CN104623637A (en) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Application of IL-22 dimer in preparation of intravenous injection drugs
EP3442562B1 (en) 2016-04-15 2022-09-21 Evive Biotechnology (Shanghai) Ltd An il-22 dimer for use in treating necrotizing enterocolitis
TW201928064A (en) * 2017-12-21 2019-07-16 紐西蘭商紐西蘭健康創新中心管理有限公司 Method of analysis of mutations in the hepatitis B virus and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862652A1 (en) * 1995-10-13 1998-09-09 IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE Methods for predicting the outcome of persistent hbv infection and the outcome of cytokine therapy
GB9817266D0 (en) * 1998-08-07 1998-10-07 Imperial College Method
EP1140142A2 (en) * 1998-12-22 2001-10-10 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10

Also Published As

Publication number Publication date
WO2002029098A2 (en) 2002-04-11
WO2002029098A3 (en) 2003-10-16
GB0024442D0 (en) 2000-11-22

Similar Documents

Publication Publication Date Title
AU2001292125A1 (en) Genetic factors affecting the outcome of viral infections
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2001264247A1 (en) GASC1 gene
AU2002211373A1 (en) Haplotypes of the por gene
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001285743A1 (en) Adipose-related gene
AU2001284265A1 (en) Genetic study
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU2002233499A1 (en) Single nucelotide polymorphisms of the seek1 gene associated withpsoriasis
AU2001290603A1 (en) Haplotypes of the or11a1 gene
AU2001255330A1 (en) Haplotypes of the akr1b1 gene
AU2002230657A1 (en) Haplotypes of the sah gene
AU2001273117A1 (en) Haplotypes of the appbp1 gene
AU2001249650A1 (en) Haplotypes of the chrnb3 gene
AU2001274995A1 (en) Haplotypes of the rlbp1 gene
AU2002213185A1 (en) Haplotypes of the chrm5 gene
AU2002227177A1 (en) Haplotypes of the scya21 gene
AU2002245073A1 (en) Haplotypes of the f2rli gene
AU2001286644A1 (en) Haplotypes of the gng7 gene
AU2001292815A1 (en) Haplotypes of the scya8 gene
AU2001255317A1 (en) Haplotypes of the ache gene
AU2001290575A1 (en) Haplotypes of the tacr1 gene
AU2002210985A1 (en) Pca2501 gene
AU2001266759A1 (en) Haplotypes of the acp2 gene
AU2001276857A1 (en) Haplotypes of the gcnt1 gene